Clinical Review
New Therapies
The Future of Progressive Multiple Sclerosis Therapies
Disease modifying therapy development presents opportunities for advancing treatments for progressive multiple sclerosis
New Therapies
Multiple Sclerosis Medications in the VHA: Delivering Specialty, High-Cost, Pharmacy Care in a National System
Disease modifying therapies that offer advantages for patients with multiple sclerosis are entering clinical trials and are rapidly being approved...
Best Practices
Behavioral Interventions in Multiple Sclerosis
Behavioral interventions can improve many of the most common and disabling symptoms in multiple sclerosis.
Best Practices
The Multiple Sclerosis Surveillance Registry: A Novel Interactive Database Within the Veterans Health Administration
The VA MS Surveillance Registry combines a traditional MS registry with individual clinical and utilization data within the largest integrated...
Clinical Review
Penicillin Allergy Delabeling Can Decrease Antibiotic Resistance, Reduce Costs, and Optimize Patient Outcomes
Many patients report an allergy to penicillin, but only a small portion have a true immune-mediated allergy, which results in a significant...
Clinical Review
Serotonin Syndrome/Serotonin Toxicity
Serotonin toxicity can result from lethal combinations of commonly prescribed medications frequently used to treat veterans.